Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty

Journal of Paediatrics and Child Health

Volumn 48, Issue 3, 2012, Pages

  Johnson, Stephanie R ^a   Nolan, Richard C ^a   Grant, Maree T ^a   Price, Glynis J ^a   Siafarikas, Aris ^a,b   Bint, Lewis ^a   Choong, Catherine S Y ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

GnRH analogue; precocious puberty; sterile abscess

Indexed keywords

FOLLITROPIN; GONADORELIN; LEUPRORELIN; LUTEINIZING HORMONE;

ABSCESS; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CENTRAL PRECOCIOUS PUBERTY; CHILD; DRUG INDUCED DISEASE; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INJECTION SITE REACTION; LUTEINIZING HORMONE BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SCHOOL CHILD; STERILE ABSCESS;

ABSCESS; CHILD; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; LEUPROLIDE; PUBERTY, PRECOCIOUS;

EID: 84858439021     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2011.02083.x     Document Type: Article

References (12)

1. Carel JC, Eugster EA, Rogol A, et al,. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009; 123: e752-62.
2. Magiakou MA, Manousaki D, Papadaki M, et al,. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J. Clin. Endocrinol. Metab. 2010; 95: 109-17.
3. Periti P, Mazzei T, Mini E,. Clinical pharmacokinetics of depot leuprorelin. Clin. Pharmacokinet. 2002; 41: 485-504.
4. Tonini G, Marinoni S, Forleo V, Rustico M,. Local reactions to luteinizing hormone releasing hormone analog therapy. J. Pediatr. 1995; 126: 159-60.
5. Neely EK, Hintz RL, Parker B, et al,. Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J. Pediatr. 1992; 121: 634-40.
6. Manasco PK, Pescovitz OH, Blizzard RM,. Local reactions to depot leuprolide therapy for central precocious puberty. J. Pediatr. 1993; 123: 334-5.
7. Watanabe T, Yamada N, Yoshida Y, Yamamoto O,. A morphological study of granulomas induced by subcutaneous injection of leuprorelin acetate. J. Cutan. Pathol. 2009; 36: 1299-302.
8. Pietrzak WS, Sarver D, Verstynen M,. Bioresorbable implants-practical considerations. Bone 1996; 19 (1 Suppl): 109S-19S.
9. Apikian M, Roberts S, Goodman GJ,. Adverse reactions to polylactic acid injections in the periorbital area. J. Cosmet. Dermatol. 2007; 6: 95-101.
10. General recommendations on immunization. Guidelines from the Immunization Practices Advisory Committee. Centers for Disease Control. Ann. Intern. Med. 1989; 111: 133-42.
11. Carel JC, Leger J,. Clinical practice. Precocious puberty. N. Engl. J. Med. 2008; 358 (22): 2366-77.
12. Antoniazzi F, Zamboni G,. Central precocious puberty: current treatment options. Paediatr. Drugs. 2004; 6 (4): 211-31.